⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 18 in last 7 days 🍎 Food: 180 in last 7 days 🧸 Products: 48 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 3 hours ago ⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 18 in last 7 days 🍎 Food: 180 in last 7 days 🧸 Products: 48 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 3 hours ago
🛡️ EUSW
💊 Medicines 🍎 Food 🧸 Products 🔎 Search
📊 Data
🏷 Brands 🌍 Countries ℹ️ About ✉ Unsubscribe
🇬🇧
🇬🇧 English 🇳🇱 Nederlands 🇫🇷 Français 🇩🇪 Deutsch 🇪🇸 Español 🇮🇹 Italiano 🇵🇹 Português 🇵🇱 Polski 🇸🇪 Svenska 🇷🇴 Română 🇨🇿 Čeština 🇫🇮 Suomi 🇩🇰 Dansk
💊 Medicine AT April 14, 2026

SANCUSO 3,1 mg/24 Stunden transdermales Pflaster 3,1 mg/24 h (transdermales Pflaster)

📷 Wikipedia: Granisetron · Source
SANCUSO 3,1 mg/24 Stunden transdermales Pflaster 3,1 mg/24 h (transdermales Pflaster)
📷 Wikipedia: Granisetron · Source
Parallel export is banned for this patch.
⚠️
Shortage ongoing
GRANISETRON is currently in short supply in AT.
📈 Timeline
10 days active so far
May 18, 2026 May 27, 2026

What is this? This is a skin patch that gives medicine called granisetron. It helps stop nausea and vomiting.

What's happening? The patch is not available right now. It will be back in July.

Does this affect me? If you use this patch, you may not be able to get it until July.

What should I do? Ask your pharmacist or doctor for another medicine to help with nausea.

🤖 This plain-language summary is automatically generated from the official agency notice using AI. It is for general information only — not medical advice. For decisions about your health, always consult a pharmacist or doctor and read the official source linked below.

🔬 Medical / technical details (for professionals)
Active substance(s)
GRANISETRON
Agency-published detail

🚫 Parallel export ban active · ATC: A04AA02 · Reason: Erhöhter Mehrbedarf · Marketing authorisation holder: Grünenthal GmbH, Zieglerstraße 6, 52078 Aachen, Federal Republic of Germany · Affected packs: 1 Stück Schachtel, Beutel [Nicht verfügbar, since 2026-04-10, resupply 2026-07-03]

First published
April 14, 2026
Last refreshed by us
15 hours ago
Severity (as classified)
High
Official source
https://medikamente.basg.gv.at/en/medicine-shortage

All information on this page comes from the official agency notice. We translate and summarise it; we don't add or edit facts.

❓ Frequently asked questions

▸ What is this medicine shortage alert about?
SANCUSO 3,1 mg/24 Stunden transdermales Pflaster 3,1 mg/24 h (transdermales Pflaster). Parallel export is banned for this patch.
▸ When was this alert issued?
This alert was issued on April 14, 2026 by BASG (Austria).
▸ Which countries are affected?
The alert applies to Austria.
▸ How serious is this alert?
Serious risk. A serious risk means the product or medicine can cause significant harm. Treat the alert as urgent.
▸ What should I do?
If you take this medicine, contact your pharmacist or prescribing doctor. They can advise on alternative products or substitutes. Do not stop taking prescription medicine without medical advice.
▸ Where can I find the official notice?
The full official notice is published on medikamente.basg.gv.at.

💬 Discussion

Share your experience or ask a question. Real names and email are optional but moderation friendly.

No comments yet — be the first.

We email a confirmation link. Your address stays private.

⚠️ We aggregate official notices. We do not give medical advice. For medical or legal decisions, consult the source agency and a qualified professional.